GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » KP Tissue Inc (TSX:KPT) » Definitions » Return-on-Tangible-Equity

KP Tissue (TSX:KPT) Return-on-Tangible-Equity : 10.09% (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is KP Tissue Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. KP Tissue's annualized net income for the quarter that ended in Mar. 2025 was C$6.99 Mil. KP Tissue's average shareholder tangible equity for the quarter that ended in Mar. 2025 was C$69.23 Mil. Therefore, KP Tissue's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 was 10.09%.

The historical rank and industry rank for KP Tissue's Return-on-Tangible-Equity or its related term are showing as below:

TSX:KPT' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -22.73   Med: -3.96   Max: 4.33
Current: 4.33

During the past 13 years, KP Tissue's highest Return-on-Tangible-Equity was 4.33%. The lowest was -22.73%. And the median was -3.96%.

TSX:KPT's Return-on-Tangible-Equity is ranked worse than
63.72% of 1822 companies
in the Consumer Packaged Goods industry
Industry Median: 8.285 vs TSX:KPT: 4.33

KP Tissue Return-on-Tangible-Equity Historical Data

The historical data trend for KP Tissue's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KP Tissue Return-on-Tangible-Equity Chart

KP Tissue Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.72 1.74 -13.67 -6.93 3.53

KP Tissue Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.51 6.69 11.72 -11.29 10.09

Competitive Comparison of KP Tissue's Return-on-Tangible-Equity

For the Household & Personal Products subindustry, KP Tissue's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KP Tissue's Return-on-Tangible-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, KP Tissue's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where KP Tissue's Return-on-Tangible-Equity falls into.


;
;

KP Tissue Return-on-Tangible-Equity Calculation

KP Tissue's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=2.433/( (68.357+69.517 )/ 2 )
=2.433/68.937
=3.53 %

KP Tissue's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=6.988/( (69.517+68.952)/ 2 )
=6.988/69.2345
=10.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


KP Tissue  (TSX:KPT) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


KP Tissue Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of KP Tissue's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


KP Tissue Business Description

Traded in Other Exchanges
Address
2 Prologis Boulevard, Suite 500, Mississauga, ON, CAN, L5W 0G8
KP Tissue Inc is a holding company. Through its equity holdings in Kruger Products Inc. (the operating company), it is involved in the business of producing, distributing, marketing, and selling various disposable tissue products, including bathroom tissue, facial tissue, paper towels, and napkins for both the consumer and away-from-home markets in North America. The products are marketed under several trademarks, such as Cashmere, Purex, SpongeTowels, Esteem, White Swan, Embassy, and others. A majority of its revenue is generated from the sale of tissue products in the consumer market. Geographically, the company derives maximum revenue from Canada and the rest from the United States.
Executives
Mario Gosselin Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Michael Keays Senior Officer
David A Spraley Director, Director or Senior Officer of 10% Security Holder, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Sarah Astrea Kruger Director, Director or Senior Officer of 10% Security Holder, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Dino Joe Bianco Director, Senior Officer
David Angel Director or Senior Officer of 10% Security Holder
Michel Letellier Director

KP Tissue Headlines

No Headlines